Skytrofa® (lonapegsomatropin-tcgd) – New orphan drug approval
August 25, 2021 - Ascendis Pharma announced the FDA approval of Skytrofa (lonapegsomatropin-tcgd), for the treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH).
Top